We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

6 hedge funds and large institutions have $959K invested in Aethlon Medical in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.28% more ownership

Funds ownership: 5.05% → 5.33% (+0.28%)

14% less funds holding

Funds holding: 7 → 6 (-1)

38% less capital invested

Capital invested by funds: $1.54M → $959K (-$576K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$70.8K
2
TSS
Two Sigma Securities
New York
+$70.8K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$50K
2
SAM
Shamrock Asset Management
Texas
-$50K
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$20K
4
BWM
BT Wealth Management
Georgia
-$11K

AEMD Hedge Fund Activity: Q1 2019 in Review

6 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2019, worth a combined $959K — down 38% from $1.54M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of AEMD and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Geode Capital Management, adding an estimated $70.8K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $50K sold.

  • 6 institutional investors held Aethlon Medical (AEMD) as of Q1 2019, down from 7 in Q4 2018.
  • Funds reported $959K of Aethlon Medical stock for Q1 2019, down 38% quarter-over-quarter.
  • 1 fund opened new Aethlon Medical positions in Q1 2019 and 2 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q1 2019 was Geode Capital Management, an estimated $70.8K added.
  • The largest Aethlon Medical seller in Q1 2019 was Bank of New York Mellon, an estimated $50K sold.

Based on aggregated 13F filings for Q1 2019.